Constellation Pharmaceuticals, Inc.

Home » Constellation Pharmaceuticals, Inc.

IPO

Constellation Pharmaceuticals, Inc.

We are a clinical-stage biopharmaceutical company using our expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance.

Symbol

CNST

Price Range
$14.00 - $16.00

Final Shares
5,300,000

Anticipated Date
TBD

Underwriters
J.P. Morgan, Jefferies, BMO Capital Markets, Oppenheimer & Co.

To view the prospectus for Constellation Pharmaceuticals, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253